New imaging study aims to spare patients painful liver biopsies
NCT ID NCT02754037
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether special PET scans can accurately measure fat, swelling, and scarring in the liver of people with non-alcoholic fatty liver disease (NAFLD). Researchers will compare scan results with standard liver biopsies from 120 adults. If successful, this could lead to a non-invasive way to diagnose and monitor liver disease without needles.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
University of California Davis Medical Center
Sacramento, California, 95817, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a promising NAFLD drug safely mix with other medicines? a trial seeks answers
- New ultrasound device could replace costly MRI for liver disease detection
- Bee product could tame fatty liver and blood fats
- Diabetes drugs may reverse fatty liver damage in new trial
- Can Omega-3 and diet advice tame fatty liver disease?
- Automated blood test strategy could spot hidden liver disease in routine checkups